Replies to post #1711 on Zynerba Pharmaceuticals (ZYNE)

[lumpy9200]

From what I read, Cramer said to "steer clear" of ZYNE, but if you want to be in the sector then you should buy GW.

I know Cramer has a little influence and you see some movement the day after he speaks highly or poorly about a company, but the simple fact is that he knows absolutely nothing about ZYNE in my opinion. No one can be an expert on every company, and when it comes to biotechs you won't know squat unless you spend serious time doing your due diligence. There's zero chance that Jim Cramer spent hours researching Zynerba and getting a thorough understanding of where the company is on all of its different trials. I'm not saying you said differently of course. I'm just offering up my opinion. And I like his show. I find it entertaining. But he can't be an expert on every sector, let alone every company.

Best to all ZYNE longs,
G

[iluvtofu]

Cramer said, "No no to Zynerba Pharmaceuticals and if you want to play cannabinoids or special needs, if you want it, then GW Pharmaceuticals is the way to play it".

A lot of sheep will sell from that quick Lighting Round remark.... At one time, Cramer championed CGC and bashed CRON, but now Cramer is totally onboard with CRON. So, doesn't mean anything to me...

IMO, it's a great time to accumulate more at these prices. One more week to go before ZYNE announces it's earnings. Hopefully they will beat the estimated range of -$.53 to -$.47.